Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’

Pfizer’s experimental COVID-19 antiviral pill can cut the risk of ending up in the hospital or dying by 89%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.